Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing PET Parameters in Oncologic 18F-FDG Studies
İsmet Sarikaya, Ali Sarıkaya
Journal of Nuclear Medicine Technology (2019) Vol. 48, Iss. 3, pp. 278-282
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes
Mark Jesus M. Magbanua, Wen Li, Laura van ‘t Veer
Cancers (2024) Vol. 16, Iss. 10, pp. 1879-1879
Open Access | Times Cited: 5
Prognostic Value of Pretreatment 18F-FDG-PET/CT Metabolic Parameters in Advanced High-Grade Serous Ovarian Cancer
Daniela Travaglio Morales, Mónica Coronado Poggio, C. Huerga, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 698-698
Open Access
Dynamic FDG PET/CT imaging: quantitative assessment, advantages and application in the diagnosis of malignant solid tumors
Yiling Wang, Yucheng Yang, Jinxin Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Emerging role of 18F-FDG PET/CT in Castleman disease: a review
Benjamin Koa, Austin J. Borja, Mahmoud Aly, et al.
Insights into Imaging (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 25
A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL
Ruah Alyamany, Riad El Fakih, Ahmed Alnughmush, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma
Miki Nishimori, Hitomi Iwasa, Kana Miyatake, et al.
Annals of Nuclear Medicine (2022) Vol. 36, Iss. 10, pp. 897-903
Closed Access | Times Cited: 11
eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma
Yan Gao, Lingling Yuan, Jing Zeng, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Biology of Cancer and PET Imaging: Pictorial Review
İsmet Sarikaya
Journal of Nuclear Medicine Technology (2022) Vol. 50, Iss. 2, pp. 81-89
Open Access | Times Cited: 9
Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma
Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, et al.
European Journal of Histochemistry (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 9
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
Ashley Schreier, Roberta Zappasodi, Inna Serganova, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 5
Value of 18F-FDG-PET/CT radiomics combined with clinical variables in the differential diagnosis of malignant and benign vertebral compression fractures
Xun Wang, Dandan Zhou, Yu Kong, et al.
EJNMMI Research (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Design of Novel 18F-Labeled Amino Acid Tracers Using Sulfur 18F-Fluoride Exchange Click Chemistry
Yong Huang, Hualong Chen, Lu Zhang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 294-301
Closed Access | Times Cited: 1
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions
Cristiano Pini, Margarita Kirienko, Fabrizia Gelardi, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The potential of 18F-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer
Lihua Wang, Maomei Ruan, Bei Lei, et al.
Lung Cancer (2020) Vol. 150, pp. 44-52
Closed Access | Times Cited: 10
Value of 18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen
Chong Jiang, Yue Teng, Jieyu Chen, et al.
Annals of Nuclear Medicine (2020) Vol. 34, Iss. 12, pp. 911-919
Closed Access | Times Cited: 9
Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
Gundula Rendl, Gregor Schweighofer-Zwink, Stefan Sorko, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1868-1868
Open Access | Times Cited: 6
Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines
Zarni Win, January Weiner rd, Allan Listanco, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 8
Role of multiple dual-phase 18F-FDG PET/CT metabolic parameters in differentiating adenocarcinomas from squamous cell carcinomas of the lung
Xue Liu, Qiao Zou, Yu Sun, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20180-e20180
Open Access | Times Cited: 3
18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume
James C. Reynolds, Roberto Maass‐Moreno, Anish Thomas, et al.
Journal of Nuclear Medicine (2020) Vol. 61, Iss. 11, pp. 1570-1575
Open Access | Times Cited: 6
Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-CHOP Regimen?
Chong Jiang, Chongyang Ding, Jingyan Xu, et al.
Clinical Nuclear Medicine (2020) Vol. 46, Iss. 1, pp. 1-7
Closed Access | Times Cited: 6
Influencing Factors and Prognostic Value of 18F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer
Lixia Zhang, Zhe Ren, Caiyun Xu, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 3699-3706
Open Access | Times Cited: 6
Pretherapy 18F-FDG PET/CT in Predicting Disease Relapse in Patients With Immunoglobulin G4-Related Disease: A Prospective Study
Mei‐Fang Cheng, Yue Leon Guo, Ruoh‐Fang Yen, et al.
Korean Journal of Radiology (2023) Vol. 24, Iss. 6, pp. 590-590
Open Access | Times Cited: 2
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
Virginia Liberini, Marco Rubatto, Riccardo Mimmo, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4994-4994
Open Access | Times Cited: 5
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
Pei-Ju Chuang, Hsiu-Po Wang, Yu-Jen Lin, et al.
European Radiology (2021) Vol. 31, Iss. 10, pp. 8040-8049
Closed Access | Times Cited: 4
Functional imaging for evaluation of cancers and biologically conformal radiotherapy: Past-history and present-day perspectives.
J. Lumbroso
La Presse Médicale (2022) Vol. 51, Iss. 2, pp. 104124-104124
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top